Abstract:Background Topical antioxidants and retinoids are foundational components of an effective skincare regimen. Pyrroloquinoline quinone (PQQ) is a potent free radical scavenger that supports efficient mitochondrial energy creation. An advanced antioxidant combines topical allyl PQQ with existing WEL antioxidant technology (TAP) to comprehensively address extrinsic and intrinsic skin aging. In conjunction with TAP, a double‐conjugated retinoid/alpha hydroxy acid (AHA‐Ret) designed to minimize irritation and optimize delivery was used over 12 weeks to improve the appearance of photodamaged skin. Patients/Methods Twice‐daily application of TAP and nightly application of AHA‐Ret was evaluated in female participants aged 40–65 years with FST IV–V and mild (3) to moderate (6) facial photodamage using a 10‐point grading scale. Visible improvements from baseline in lines/wrinkles, skin texture, skin tone, skin dullness and erythema were assessed using a six‐point grading scale (0 = None to 5 = Severe). Adverse Events (AEs) were captured throughout the study period. Results Participants (N = 21; mean age, 56 years) equally represented mild and moderate photodamage, and FST IV and V (41%, Hispanic; 36%, African American; and 32%, Caucasian). Significant mean improvements from baseline occurred in skin dullness, skin texture, and skin tone (all, p

Evaluation of an advanced antioxidant and double‐conjugated retinoid/AHA cream in participants with FST IV–V